Research-Grade Tamoxifen ProfileNolva 10 by Ryzen Pharmaceuticals is a selective estrogen receptor modulator (SERM) formulated for in-vitro laboratory research applications. This pharmaceutical-grade compound contains 10mg of tamoxifen citrate per unit, representing one of the most extensively studied SERMs in scientific literature. Researchers at steroidsshopuk.co.uk can investigate its unique mechanism as a competitive antagonist at estrogen receptors in specific tissue types while functioning as an agonist in others. The compound’s tissue-selective properties make it valuable for studying estrogen receptor modulation pathways and hormonal signalling mechanisms in controlled laboratory environments.Laboratory Research ApplicationsAcademic researchers investigating hormonal pathways frequently examine tamoxifen’s effects on estrogen receptor binding affinity and downstream cellular responses. Studies explore its competitive inhibition of estradiol binding at estrogen receptor sites, particularly in breast tissue models. The compound’s dual nature as both antagonist and agonist across different tissue types provides insights into selective estrogen receptor modulation mechanisms. Researchers studying post-cycle therapy protocols examine tamoxifen’s ability to stimulate luteinising hormone and follicle-stimulating hormone release through hypothalamic-pituitary axis modulation. Additionally, investigations into bone metabolism and cardiovascular effects utilise tamoxifen as a reference compound in aromatase inhibitor and tamoxifen studies. Comparative analyses with other hormonal modulators available in our SARMs and peptides collections enhance understanding of selective receptor targeting mechanisms.Technical SpecificationsNolva 10 Research Compound SpecificationsParameterValueActive CompoundTamoxifen CitrateConcentration10mg per unitManufacturerRyzen PharmaceuticalsCAS Number54965-24-1Molecular FormulaC₃₂H₃₇NO₈Molecular Weight563.64 g/molStorage RequirementsRoom temperature, protect from lightResearch ClassificationSelective Estrogen Receptor ModulatorResearch Compliance StatementNolva 10 by Ryzen Pharmaceuticals is manufactured exclusively for in-vitro laboratory research purposes and is not intended for human consumption, therapeutic use, or any clinical applications. This research chemical must be handled by qualified laboratory personnel in appropriate research facilities with proper safety protocols. Researchers must comply with all applicable local, national, and international regulations governing the use of research chemicals in laboratory settings. All studies should be conducted under appropriate institutional oversight with proper documentation and safety measures in place.